Dabur India Ltd Q4 FY2024 Concall Summary

Key Takeaways

• Rural finally leads urban: Rural consumption grew ahead of urban for the first time in three years, with rural at +8% vs urban +4%, driven by summer-centric and Ayurvedic portfolio strength.
• Power brands dragged, long tail delivered: Juices and Chyawanprash were flat or declined, pulling down overall growth, while emerging brands and the 23.2% growth in Foods carried the quarter.
• Gross margin expansion peaked: Gross margins expanded 280 bps in Q4 on deflation and cost savings, but management flagged that the rate of expansion will moderate as price increases slow, with benefits now partly reinvested in media.
• Legal overhang persists, confidence intact: The US case is in discovery with ~1.5 years to run; management expects a favorable outcome once the scientific phase begins and is pursuing insurance reimbursement for legal costs.
• What to watch next quarter: Whether power brands (juices, Chyawanprash) recover with normal monsoons, the pace of rural momentum sustaining, and operating margin progression toward the ~20% target.

Rural Recovery & Volume Growth

• Rural turnaround structural, not one-off: Rural growth moved from minus 5 to plus 6 over several quarters and now sits 120-130 bps ahead of urban, a gap management believes will persist given the three-year hiatus of rural lagging urban.
• Volume growth is non-negotiable: The company has set a mid- to high single-digit volume growth target, topped with ~3% price increase, to deliver high single to low double-digit revenue growth; volume is "no question asked, there are no compromises."
• Sustainable volume growth pegged lower: Management clarified that 7.5% volume growth is on the higher end and depends on monsoon, government stability, and consistency; a more sustainable long-term mix is 5.5% volume growth.
• Rural portfolio alignment: Dabur's rural strength is built on OTC, healthcare, oral care, hair oil, and shampoo, categories where unorganized players have limited presence, giving organized players an edge as rural recovers.
• Monsoon dependency: If monsoon is normal, agricultural output will put more money in farmers' hands, directly lifting consumption of shampoo sachets, toothpaste, and hair oil in rural markets.

Mohit Malhotra: "So after almost 3 years of time we are seeing that rural ahead of urban and I hope it is more structural in nature and not one off that we see."

Power Brand Weakness & Portfolio Mix

• Power brands underperformed: Power brands, which constitute 75-80% of business, did not fire this year: juices were flat due to unseasonal rains, Chyawanprash declined on delayed and contracted winters, pulling down overall growth while long-tail and emerging brands did the heavy lifting.
• Market share gains continued despite drag: Every power brand continued to gain market share both in the quarter and over previous years, even as absolute growth lagged; management views power brand strategy over a 4-5 year horizon, not quarter by quarter.
• Health supplements hit by seasonality: Chyawanprash suffered from limited up-stocking and actual down-stocking due to a short, mild winter; honey had crystallization issues in winter, now corrected; glucose grew 14% with market share gains.
• Beverages flat on weather and supply chain: Unseasonal rains during peak summer impacted out-of-home consumption, and supply chain issues at the new Indore plant constrained manufacturing; double-digit growth targeted for the coming year.
• Foods and home care offset weakness: Homemade brand grew 23.2%, Badshah grew 23.3% with market share gains, Odomos mosquito repellent cream expanded share by 600 bps, and Odonil air freshener gained 260 bps.

Margin Trajectory & Investment

• Gross margin expansion moderating: The 280 bps Q4 gross margin expansion was driven by deflation and price increases; going forward, the rate of price increases has come down, so gross margin expansion will not repeat at the same pace, with improvements partly invested in media and partly flowing to operating margin.
• Operating margin target ~20%: Reported operating margin was ~19.4% including legal costs; management targets ~20% for the coming year, with media spend rising from 7% to 7.5-8% of revenue.
• Samriddhi cost savings second leg: Project Samriddhi, run with a consultant, is targeting ~₹100 cr in cost savings this year, following the 240 bps annual gross margin expansion already delivered.
• Overhead disadvantage vs peers: Dabur's gross margin profile is similar to competitors, per benchmarking by BCG and McKinsey, but operating margins are lower because Dabur has only 15-16% market share, making overheads proportionately higher; scale will improve leverage over time.
• Long-term margin path is slow: Margin improvement through the advocacy vertical (now reaching allopathic doctors, not just Ayurvedic) and premiumization in mass categories like Dabur Red sensitive will take time; "it's a little slower... going to take time."

Mohit Malhotra: "volume growth is something that we have to do. It's no question asked, there are no compromises here."

Legal Case & Contingent Liabilities

• US case status quo: Depositions have happened, fact sheets received, and the discovery phase is continuing; corporate separateness has been achieved, with no Dabur entity involved except Namaste, which accounts for less than 1% of turnover.
• Timeline and confidence: The case is expected to continue for another ~1.5 years; management is confident of winning once the scientific phase begins, stating "the moment it comes to the scientific phase, I think the case will get really diluted and it will come in our favour."
• Insurance reimbursement pursued: Dabur is in litigation with insurance companies to recover legal costs incurred on the US case; legal costs for the coming year are budgeted at roughly ₹80-90 cr, with no incrementality expected.

Distribution & Channel Expansion

• Rural reach at all-time high: Distribution now covers 1.22 lakh villages through 22,000 Yodhas, with total reach at 79 lakh outlets; 2 lakh outlets were added during the year, the highest addition among all FMCG peers.
• Urban direct reach headroom: Urban direct reach can expand from 14 lakh to ~20 lakh outlets; e-commerce now contributes 9-10% of business, with quick commerce at 30% of e-commerce.
• Modern trade tertiary growth strong: Modern trade tertiary growth was 22-23% despite primary being held back by Reliance inventory cleanup.
• Therapeutic division scaling: Now covers around 1.1 lakh Ayurvedic and allopathic doctors with turnover exceeding ₹120 cr, up from 20,000 test points earlier; focused on paediatricians, dermatologists, and gynaecologists.

Category & Brand Updates

• Chyawanprash format innovation: Introducing capsule, gummy, and powder forms to modernize the format and reduce seasonality dependence.
• Summer portfolio correction: Launching Cool King talcum powders, Cool King Thanda Tel, and pushing Pudin Hara, juices, and glucose to increase Q4 summer salience, addressing the post-COVID Q4 revenue saliency drop from 25% to 22.7%.

Mohit Malhotra: "a better mix would be a 5.5% and a 54%. And that's what is the right sustainable sort of volume growth."

Guidance & Commitments

Key Metrics